Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
Frontiers in Allergy
|
October 17, 2024
The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years
V Schichter-Konfino, R Mubariki, E Toubi, et al.
Allergy
|
March 1, 1997
Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria
E Toubi, A Blant, A Kessel, et al.
Harefuah
|
May 1, 1987
[Intolerance to food additives]
E Toubi, S Kivity, D Golan, et al.
The American Journal of Medicine
|
October 1, 1995
Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus
E Toubi, M A Khamashta, A Panarra, et al.
Clinical and Experimental Rheumatology
|
August 29, 2003
IgA rheumatoid factor in patients with chronic HCV infection: prevalence and clinical correlations
E Toubi, E Zuckerman, A Kessel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 9, 2015
An individualized diagnostic approach based on guidelines for chronic urticaria (CU)
A M Giménez-Arnau, C Grattan, T Zuberbier, et al.
The Journal of Rheumatology
|
April 1, 2000
Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection
A Kessel, I Rosner, E Zuckerman, et al.
Oral Surgery, Oral Medicine, and Oral Pathology
|
June 1, 1993
Whole saliva in systemic lupus erythematosus patients
H Ben-Aryeh, N Gordon, R Szargel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 11, 2016
Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria
A M Giménez-Arnau, E Toubi, A M Marsland, et al.
Lupus
|
April 29, 2000
The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients
E Toubi, I Rosner, M Rozenbaum, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
Frontiers in Allergy
|
October 17, 2024
The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years
V Schichter-Konfino, R Mubariki, E Toubi, et al.
Allergy
|
March 1, 1997
Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria
E Toubi, A Blant, A Kessel, et al.
Harefuah
|
May 1, 1987
[Intolerance to food additives]
E Toubi, S Kivity, D Golan, et al.
The American Journal of Medicine
|
October 1, 1995
Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus
E Toubi, M A Khamashta, A Panarra, et al.
Clinical and Experimental Rheumatology
|
August 29, 2003
IgA rheumatoid factor in patients with chronic HCV infection: prevalence and clinical correlations
E Toubi, E Zuckerman, A Kessel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 9, 2015
An individualized diagnostic approach based on guidelines for chronic urticaria (CU)
A M Giménez-Arnau, C Grattan, T Zuberbier, et al.
The Journal of Rheumatology
|
April 1, 2000
Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection
A Kessel, I Rosner, E Zuckerman, et al.
Oral Surgery, Oral Medicine, and Oral Pathology
|
June 1, 1993
Whole saliva in systemic lupus erythematosus patients
H Ben-Aryeh, N Gordon, R Szargel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 11, 2016
Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria
A M Giménez-Arnau, E Toubi, A M Marsland, et al.
Lupus
|
April 29, 2000
The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients
E Toubi, I Rosner, M Rozenbaum, et al.
Page
of 9